Charles River

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Charles River and other ETFs, options, and stocks.

About CRL

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 

CEO
Birgit Girshick
CEOBirgit Girshick
Employees
19,700
Employees19,700
Headquarters
Wilmington, Massachusetts
HeadquartersWilmington, Massachusetts
Founded
1947
Founded1947
Employees
19,700
Employees19,700

CRL Key Statistics

Market cap
7.72B
Market cap7.72B
Price-Earnings ratio
-42.63
Price-Earnings ratio-42.63
Dividend yield
Dividend yield
Average volume
950.10K
Average volume950.10K
High today
High today
Low today
Low today
Open price
$160.41
Open price$160.41
Volume
0.00
Volume0.00
52 Week high
$228.88
52 Week high$228.88
52 Week low
$132.58
52 Week low$132.58

Stock Snapshot

The current Charles River(CRL) stock price is $160.30, with a market capitalization of 7.72B. The stock trades at a price-to-earnings (P/E) ratio of -42.63.

Charles River(CRL) stock opened on 2026-05-26 at $160.41. The price climbed to — and dipped to —.

Charles River(CRL) shares are trading with a volume of 0, against a daily average of 950.1K.

In the last year, Charles River(CRL) shares hit a 52-week high of $228.88 and a 52-week low of $132.58.

In the last year, Charles River(CRL) shares hit a 52-week high of $228.88 and a 52-week low of $132.58.

CRL News

MarketWatch 5d
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch

...

Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MarketWatch
Simply Wall St 5d
Should Higher Impairments and AI Investments Shape a New Capital Allocation Playbook for Charles River?

In May 2026, Charles River Laboratories reported first-quarter revenue of US$995.83 million with a net loss of US$14.84 million, raised full-year GAAP EPS guida...

Should Higher Impairments and AI Investments Shape a New Capital Allocation Playbook for Charles River?

Analyst ratings

60%

of 20 ratings
Buy
60%
Hold
35%
Sell
5%

People also own

Based on the portfolios of people who own CRL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.